Evidence map›Paper›PMID 25944790›Full record

ArticleShock (Augusta, Ga.)2015

α-Enolase Causes Proinflammatory Activation of Pulmonary Microvascular Endothelial Cells and Primes Neutrophils Through Plasmin Activation of Protease-Activated Receptor 2.

Ashley Bock, Nicole Tucker, Marguerite R Kelher, Samina Y Khan, Eduardo Gonzalez, Max Wohlauer, Kirk Hansen, Monika Dzieciatkowska, Angels Sauaia, Anirban Banerjee and 2 more

Abstract read
In one paragraph

Article in Shock (Augusta, Ga.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Enolase-1 and Inflammation.Biomolecules · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ashley Bock*Research Laboratory Bonfils Blood Center and †School of Medicine, University of Colorado Denver; Departments of ‡Surgery, §Pediatrics, and ∥Cell Biology, School of Medicine, University of Colorado Denver, Aurora; and ¶School of Public Health, University of Colorado; and **Department of Surgery Denver Health Medical Center, Denver, Colorado.
Nicole Tucker
Marguerite R Kelher
Samina Y Khan
Eduardo Gonzalez
Max Wohlauer
Kirk Hansen
Monika Dzieciatkowska
Angels Sauaia
Anirban Banerjee
Ernest E Moore
Christopher C Silliman
University of Colorado Denver · USDenver Health Medical Center · US

Funding

Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Trauma Reprograms CellsP50GM049222 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI BANERJEE, ANIRBAN · 1993 to 2017
$26.1M
NCATS NIH HHS UL1 TR001082NIGMS NIH HHS P50 GM049222
6 · The paper itself

Abstract

unlabelledProinflammatory activation of vascular endothelium leading to increased surface expression of adhesion molecules and neutrophil (PMN) sequestration and subsequent activation is paramount in the development of acute lung injury and organ injury in injured patients. We hypothesize that α-enolase, which accumulates in injured patients, primes PMNs and causes proinflammatory activation of endothelial cells leading to PMN-mediated cytotoxicity.

methodsProteomic analyses of field plasma samples from injured versus healthy patients were used for protein identification. Human pulmonary microvascular endothelial cells (HMVECs) were incubated with α-enolase or thrombin, and intercellular adhesion molecule-1 surface expression was measured by flow cytometry. A two-event in vitro model of PMN cytotoxicity HMVECs activated with α-enolase, thrombin, or buffer was used as targets for lysophosphatidylcholine-primed or buffer-treated PMNs. The PMN priming activity of α-enolase was completed, and lysates from both PMNs and HMVECs were immunoblotted for protease-activated receptor 1 (PAR-1) and PAR-2 and coprecipitation of α-enolase with PAR-2 and plasminogen/plasmin.

resultsα-Enolase increased 10.8-fold in injured patients (P < 0.05). Thrombin and α-enolase significantly increased intercellular adhesion molecule-1 surface expression on HMVECs, which was inhibited by antiproteases, induced PMN adherence, and served as the first event in the two-event model of PMN cytotoxicity. α-Enolase coprecipitated with PAR-2 and plasminogen/plasmin on HMVECs and PMNs and induced PMN priming, which was inhibited by tranexamic acid, and enzymatic activity was not required.

conclusionsα-Enolase increases after injury and may activate pulmonary endothelial cells and prime PMNs through plasmin activity and PAR-2 activation. Such proinflammatory endothelial activation may predispose to PMN-mediated organ injury.

Indexed as

MicrocirculationAcute Lung InjuryCell MembraneEndothelial CellsFlow CytometryHumansInflammationIntercellular Adhesion Molecule-1LungNeutrophilsPhosphopyruvate HydratasePlasminogenProteomicsReceptor, PAR-2ThrombinTranexamic AcidICAM1 protein, humanIntercellular Adhesion Molecule-1Phosphopyruvate HydratasePlasminogenReceptor, PAR-2ThrombinTranexamic Acid

Identifiers

PMID25944790
PMCPMC4506257
OpenAlexW2401415035

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.